MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$13,449K
EPS
$0.22
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development expenses
1,644
General and administrative expenses
1,820
Intangible asset and goodwill impairment expenses
9,684
Operating loss
-13,148
Financial expense (income), net
57
Loss before tax expenses
-13,091
Tax expenses
358
Net loss and comprehensive loss
-13,449
Basic EPS
0.22
Diluted EPS
0.22
Basic Average Shares
60,729,100
Diluted Average Shares
60,729,100
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss andcomprehensive loss-$13,449K Loss before taxexpenses-$13,091K Tax expenses$358K Financial expense(income), net$57K Operating loss-$13,148K Intangible asset andgoodwill impairment...$9,684K General andadministrative expenses$1,820K Research and developmentexpenses$1,644K

Revium Rx. (RVRC)

Revium Rx. (RVRC)